Disqus Shortname

Breaking News

Home / News18 / Top India News- News18.com / SII to Apply for DCGI Approval for Covovax Trial on Children; Vaccine has Great Potential to Save Future Generation, Says CEO

SII to Apply for DCGI Approval for Covovax Trial on Children; Vaccine has Great Potential to Save Future Generation, Says CEO

يونيو 26, 2021 ,
Covovax is the second Covid-19 vaccine candidate, which is being developed and manufactured at Pune-based SII.

from Top India News- News18.com https://ift.tt/2U2UQcr
via IFTTT

ليست هناك تعليقات

الاشتراك في: تعليقات الرسالة ( Atom )